Skyrizi Kit
Product Images NDC 0074-1065
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 86 technical images submitted to the FDA as part of the official labeling for Skyrizi (NDC 0074-1065). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Skyrizi 02
This text provides a list of physical features of an item that appears to be related to medical injections. It includes a green activator button, gray hand grips, an inspection window, a white needle sleeve, a needle, and a dark gray cap. The text suggests that the dark gray cap should be kept on the item until it is ready to be used for injection.*
Skyrizi 03
Skyrizi 04
Skyrizi 05
Skyrizi 06
Skyrizi 07
Skyrizi 08
Skyrizi 09
Skyrizi 0a
Skyrizi 0b
Skyrizi 0c
Skyrizi 0d
Skyrizi 0e
Skyrizi 0f
Skyrizi 10
Skyrizi 11
Skyrizi 12
Skyrizi 13
Skyrizi 14
Skyrizi 15
Skyrizi 16
Skyrizi 17
Skyrizi 18
Skyrizi 19
Skyrizi 1a
This text is a set of instructions related to using two syringes to inject a substance into a body. The instruction is to make sure that when using the second syringe, the injection site should be at least 1 inch away from the first site and not to inject the substance into the same site as the first one.*
Skyrizi 1b
Skyrizi 1c
Skyrizi 1d
Skyrizi 1e
Skyrizi 1f
Skyrizi 20
Skyrizi 21
This appears to be a description of an on-body injector, with a front view depicted. It features an adhesive, a gray start button, a light material that should not be touched until ready to inject, a gray door which should not be closed without a prefilled cartridge of medicine inside, and pull tabs. The purpose of this on-body injector and the type of medicine it may dispense is not specified.*
Skyrizi 22
This appears to be a product label with instructions for a needle and adhesive plastic cover. It includes information on the needle, the plastic backing strip, and a warning not to touch the needle cover. There are also two sections labeled with green pull tabs, but it is unclear what they refer to.*
Skyrizi 23
This is a description of a side view of a device that contains a gray door with ridges, a door latch, a needle cover and a needle. The instructions state that the gray door should be slightly open and should not be closed without a prefilled cartridge inside. It is also advised not to touch the needle cover or needle.*
Skyrizi 24
This is a description for a prefilled cartridge used for medications. The cartridge has a larger size and a white plunger that expands through the chamber toward the bottom of the cartridge as medication is delivered. There is an expiration date (EXP) located on the cartridge label, and caution instructions not to twist or remove the cartridge top.*
Skyrizi 25
Skyrizi 26
Skyrizi 27
Skyrizi 28
Skyrizi 29
Skyrizi 2a
Skyrizi 2b
Skyrizi 2c
Skyrizi 2d
Skyrizi 2e
Skyrizi 2f
Skyrizi 30
Skyrizi 31
Skyrizi 32
Skyrizi 33
Skyrizi 34
Skyrizi 35
This text seems to be a partial instruction guide for a medication called SKYRIZI. It provides a phone number that can be used for assistance related to the usage of this medication. Additionally, there is an instruction related to the proper handling of an on-body injector, which should be carefully removed from the ski. Unfortunately, the text is incomplete and does not provide further context.*
Skyrizi 36
Skyrizi 37
Skyrizi 38
Skyrizi 39
Skyrizi 3a
Skyrizi 3b
Skyrizi 3c
Skyrizi 3d
Skyrizi 3e
Skyrizi 3f
Skyrizi 40
Skyrizi 41
Skyrizi 42
Skyrizi 43
Skyrizi 44
Skyrizi 45
Skyrizi 46
Skyrizi 47
Skyrizi 48
Skyrizi 49
Skyrizi 4a
Skyrizi 4b
Skyrizi 4c
Skyrizi 4d
Skyrizi 4e
Skyrizi 4f
Skyrizi 50
Skyrizi 51
Skyrizi 52
Skyrizi 53
Skyrizi 54
Skyrizi 55
Skyrizi 56
This is medication information for Skyrizi, an injection containing risankizumab-rzaa, with a concentration of 600 mg/10 mL. This medication is for intravenous use only, and must be diluted prior to use. The 10 mL single-dose vial must be kept refrigerated at 36°F to 46°F to protect it from the light. Each vial contains 600 mg of medication, and the dosage instructions should be obtained from the prescribing information. The medication is manufactured by AbbVie Inc. and can be found on www.SKYRIZI.com.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.